Clinical Trial

Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The study focuses on patients with locally advanced gastric adenocarcinoma (cT3N+M0 and cT4aN+/-M0), assessing the feasibility, surgical safety, and oncological benefit of prophylactic HIPEC treatment following laparoscopic D2 radical surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-25.
Trial Details
NCT Number NCT06525714
Lead Sponsor The First Hospital of Jilin University
Conditions Gastric Cancer, Survival Rate
Enrollment 302 participants
Start Date 2024-08
Primary Completion 2029-07 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2024-07-31